An update from Livzon Pharmaceutical Group ( (HK:1513) ) is now available.
Livzon Pharmaceutical Group Inc. announced the resignation of Mr. Yang Liang from his position as vice president and all other roles within the company and its subsidiaries, effective immediately. His departure, due to personal career development reasons, is not expected to impact the company’s operations. The board expressed gratitude for Mr. Yang’s diligent service and confirmed there are no disagreements or issues to report to shareholders.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development and production of pharmaceutical products. The company is based in Zhuhai, China, and is publicly listed on the Hong Kong Stock Exchange.
YTD Price Performance: 1.16%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.08B
For detailed information about 1513 stock, go to TipRanks’ Stock Analysis page.